Recombinant multi-species CEP290 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CEP290 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a protein with 13 putative coiled-coil domains, a region with homology to SMC chromosome segregation ATPases, six KID motifs, three tropomyosin homology domains and an ATP/GTP binding site motif A. The protein is localized to the centrosome and cilia and has sites for N-glycosylation, tyrosine sulfation, phosphorylation, N-myristoylation, and amidation. Mutations in this gene have been associated with Joubert syndrome and nephronophthisis and the presence of antibodies against this protein is associated with several forms of cancer. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 3H11Ag,BBS14,Bardet-Biedl syndrome 14 protein,CEP290,CT87,Cancer/testis antigen 87 (CT87),Centrosomal protein of 290 kDa,Cep290,JBTS5,LCA10,MKS4,NPHP6,Nephrocystin-6,Nphp6,POC3,RGD1311640,SLSN6,Tumor antigen se2-2,b2b1454Clo,b2b1752Clo,rd16

Target products collectionGo to CEP290 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP12423-Ag-1/ GM-Tg-hg-IP12423-Ag-2 Human CEP290 protein Human
GM-Tg-rg-IP12423-Ag-1/ GM-Tg-rg-IP12423-Ag-2 Rat CEP290 protein Rat
GM-Tg-mg-IP12423-Ag-1/ GM-Tg-mg-IP12423-Ag-2 Mouse CEP290 protein Mouse
GM-Tg-cynog-IP12423-Ag-1/ GM-Tg-cynog-IP12423-Ag-2 Cynomolgus/Rhesus macaque CEP290 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP12423-Ag-1/ GM-Tg-felg-IP12423-Ag-2 Feline CEP290 protein Feline
GM-Tg-cang-IP12423-Ag-1/ GM-Tg-cang-IP12423-Ag-2 Canine CEP290 protein Canine
GM-Tg-bovg-IP12423-Ag-1/ GM-Tg-bovg-IP12423-Ag-2 Bovine CEP290 protein Bovine
GM-Tg-equg-IP12423-Ag-1/ GM-Tg-equg-IP12423-Ag-2 Equine CEP290 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP12423-Ag-1/ GM-Tg-hg-IP12423-Ag-2; GM-Tg-rg-IP12423-Ag-1/ GM-Tg-rg-IP12423-Ag-2;
GM-Tg-mg-IP12423-Ag-1/ GM-Tg-mg-IP12423-Ag-2; GM-Tg-cynog-IP12423-Ag-1/ GM-Tg-cynog-IP12423-Ag-2;
GM-Tg-felg-IP12423-Ag-1/ GM-Tg-felg-IP12423-Ag-2; GM-Tg-cang-IP12423-Ag-1/ GM-Tg-cang-IP12423-Ag-2;
GM-Tg-bovg-IP12423-Ag-1/ GM-Tg-bovg-IP12423-Ag-2; GM-Tg-equg-IP12423-Ag-1/ GM-Tg-equg-IP12423-Ag-2
Products Name CEP290 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CEP290
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CEP290 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.